-
Williams-Alcaraz fall in US Open mixed quarter-finals
-
'Final Fantasy', 'The Witcher' in spotlight at Europe gaming bash
-
Mark Carney, the former central banker who said 'no' to Trump
-
Syrian Kurdish leader dissolves force that spearheaded jihadist fight
-
Segner out of South Africa tour as New Zealand injuries pile up
-
Trump raises prospect of demolishing iconic Kennedy Center
-
Meta knew teen safety tools were ineffective, witnesses testify
-
PGA Tour to end in two-week matchplay showdown from 2028: CEO
-
Williams and Alcaraz win opener at US Open mixed doubles
-
United States of Dolly: how a country queen bridged America's divide
-
Man Utd's Fernandes crowned PFA player of the year
-
PGA chief says 'no current plans' for LIV stars to return
-
Dolly Parton: quotes on life, love and music
-
Golf giant Callaway apologizes after ad sparks outcry
-
Brazil fines TikTok $30 mn in 'powerful signal' over child safety
-
Ioane stars as New Zealand recover to beat Johannesburg Lions
-
Cameroon's Baleba joins as Man Utd boost midfield options
-
Ukrainians seeking beauty in a bomb-scarred city
-
US country music legend Dolly Parton dies at 80
-
Dolly Parton: Country music's dolled up but deserving queen
-
Kolisi fit to captain South Africa against New Zealand
-
US robotaxi firm Waymo plans to launch in Germany
-
Volkswagen workers boo boss during speech on job cuts
-
'Here to win': Xavi vows to restore pride in Dutch football
-
Djokovic, Sabalenka tumble out of US Open mixed doubles
-
Cameroon's Baleba joins as Man United boost midfield options
-
CIA director Ratcliffe visits Moscow: US media
-
'Shocking' book about Putin's private life wins French literary prize
-
Trump threatens to rename Lake Ontario as 'Lake America'
-
Pogacar storms to Vuelta a Espana stage four solo triumph
-
'Here to win': Xavi vows to restore pride to Dutch football
-
Canada unveils counter-tariffs of 15-50% on US goods
-
Canada unveils counter tariffs of 15% to 50% on US goods
-
Volkswagen boss braces German workers for more job cuts
-
Spain moves to speed up return of migrants stranded in Ceuta
-
Olympic champion Brignone to undergo new knee operation
-
At least a quarter of NFL players may get brain disease: study
-
The summer climate change became scorching reality for Europe
-
Iranians queue for petrol after US announces new sanctions
-
Root angered by England's off-field 'stupid mistakes'
-
Blockchain Infrastructure Firm tZERO Integrates with Sui for Institutional-Grade Digital Asset Securities
-
Welsh rugby league 'giant' Boston dies, aged 92
-
Oil down as traders weigh US sanctions threat against Iran
-
Root annoyed by England's off-field 'stupid mistakes'
-
Canada to unveil response to Trump's steep tariffs
-
One million Afghan children suffer 'life-threatening' malnutrition: UN
-
Curling attracts curious Romans under Colosseum's shadow
-
Sri Lanka trail India by 238 runs in second Test
-
World must rein in autonomous weapons: UN, Red Cross
-
West Bank settlers attack AFP journalists
CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned
SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2026 / CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC Holding Inc. Under the terms of this agreement, CBD Life Sciences Inc. has purchased 100% of the issued and outstanding stock of Mushroom Madness Inc. and Formrunner Apparel.
This strategic acquisition ensures that both Mushroom Madness Inc. and Formrunner Apparel are now fully wholly owned subsidiaries of CBD Life Sciences Inc. (CBDL). This move represents a significant milestone in our corporate growth strategy, streamlining our operations and consolidating our diverse brand portfolio under the CBD Life Sciences umbrella to maximize shareholder value and operational efficiency
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [email protected]
Website: https://www.thecbdvault.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson CEO
[email protected]
4802091720
SOURCE: CBD Life Sciences Inc.
View the original press release on ACCESS Newswire
B.Torres--AT